Gritstone Oncology Inc. has launched with $102 million and betting that its vaccines will improve the ability of certain immuno-oncology drugs to treat lung cancer. Versant Ventures, which backed Clovis and Pharmion, is leading this Series A round with Column Group.
Investors are placing increasing bets on two traditional industries confronted by changing consumer tastes: food and beverage businesses and agriculture. One significant new contributor to that trend is S2G Ventures in Chicago.
San Carlos-based ShopWell, which offers a nutrition app, raised $3.4 million in a round led by Finistere Ventures, with participation from Fairhaven Capital, Munich Venture Partners, S2G Ventures, and ATA Ventures. This brings the company's total funding to about $11.4 million.